Go to deals
Private Equity | Healthcare

DCN Dx has received a growth equity investment from Martis Capital

DCN Dx, a leading provider of contract development services, has received a growth equity investment from Martis Capital.

DCN Dx offers contract development services for clients seeking to explore, develop and commercialize rapid diagnostic tests related to lateral flow assay. DCN Dx supports an array of customers including global diagnostics manufacturers, nonprofits seeking tests for low-resource settings and start-ups launching diagnostic-based products. Over the past 15 years, DCN Dx has successfully developed more than 100 rapid diagnostic tests for its customers.

Martis Capital is a private equity firm which manages more than US$1.2 billion of equity and is focused exclusively on investing in middle-market growth companies in the healthcare industry.

One of Oaklins’ teams in the USA, together with Pegasus Capital, served as a financial advisor to DCN Dx, in connection with a growth equity investment from Martis Capital.

Service
M&A sell-side
Parties

Talk to the deal team

 Bradford A. Adams

Bradford A. Adams

Managing Director

Boston, United States
Oaklins TM Capital
 Michael S. Goldman

Michael S. Goldman

Managing Director

New York, United States
Oaklins TM Capital
 James  McLaren

James McLaren

Managing Director

New York, United States
Oaklins TM Capital

Related deals

VHZ Group has been acquired by Gilde Equity Management and VHZ Group’s management
Private Equity | Construction & Engineering Services

VHZ Group has been acquired by Gilde Equity Management and VHZ Group’s management

VHZ Group, the market leader in the Dutch B2B uPVC windows and doors market, has been acquired by Gilde Equity Management (GEM) together with the company’s management. With the acquisition, VHZ Group and GEM will be able to further expand on the company’s strategy and vision.

Learn more
ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners
Healthcare | TMT

ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners

Netherlands-based ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning software to improve early detection of breast cancer, has raised US$28 million (€24 million) in a Series C funding round led by New York-based global venture capital and private equity firm Insight Partners to further develop its technology and accelerate commercial growth of the company’s Transpara AI breast care software.

Learn more
esignatur has been acquired by Scrive
Private Equity | TMT

esignatur has been acquired by Scrive

esignatur has been acquired by Scrive, a portfolio company of Vitruvian Partners. esignatur and Scrive both specialize in digital signing solutions and complement each other with strong geographical and sector reach.

Learn more